1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM)
    Meeting Abstract

    Hellmann, M. D.; Borsu, L.; Zehir, A.; Cheng, D. T.; Zha, Z.; Siegel, B.; Rohrer, R. W.; Robson, M. E.; Arnold, A. G.; Fleischut, M. H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics and prognostic impact of MET receptor overexpression in patients with stage I-IIIA squamous cell lung carcinomas (SQCLCs)
    Meeting Abstract

    Hellmann, M. D.; Anderson, T. A.; Eng, J.; Sima, C. S.; Kris, M. G.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A multicenter phase II study of docosahexaenoic acid (DHA) in patients (pts) with a history of breast cancer (BC), premalignant lesions, or benign breast disease
    Meeting Abstract

    Gucalp, A.; Morris, P. G.; Zhou, X. K.; Giri, D. D.; Iyengar, N. M.; Crew, K. D.; Hershman, D. L.; Garber, J. E.; Nangla, J. R.; Cook, E. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • CK14, FOXA1, and androgen receptor (AR) expression in patients (pts) with triple-negative breast cancer (TNBC)
    Meeting Abstract

    Gucalp, A.; Krasne, M. D.; Jakate, K. A.; Drill, E. N.; Wen, Y. H.; Akram, M.; Ho, A. Y.; Gupta, G. P.; Brogi, E.; Hudis, C. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II trial of temsirolimus plus low-dose weekly carboplatin and paclitaxel for recurrent/metastatic HNSCC
    Meeting Abstract

    Fury, M. G.; Xiao, H.; Baxi, S. S.; Sherman, E. J.; Smith-Marrone, S.; Ho, A. L.; Sima, C. S.; Nwankwo, O. G.; Haque, S.; Katabi, N.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas
    Meeting Abstract

    Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers
    Meeting Abstract

    Drilon, A. E.; Hellmann, M. D.; Wang, L.; Cho, E. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history
    Meeting Abstract

    Drilon, A. E.; Wang, L.; Arcila, M. E.; Cho, E. J.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Mcarthur, H. L.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Maybody, M.; Durack, J. C.; Blum, B.; Yuan, J. D.; Patil, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • PD-LI expression and immune infiltrates in sarcoma
    Meeting Abstract

    D'Angelo, S. P.; Shoushtari, A. N.; Agaram, N. P.; Kuk, D.; Qin, L. X.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save